GSA Capital Partners LLP Has $1.62 Million Stock Holdings in Humana Inc. (NYSE:HUM)

GSA Capital Partners LLP decreased its holdings in shares of Humana Inc. (NYSE:HUM) by 6.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,684 shares of the insurance provider’s stock after selling 333 shares during the quarter. GSA Capital Partners LLP’s holdings in Humana were worth $1,624,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in HUM. Norges Bank acquired a new stake in Humana during the 4th quarter valued at $676,800,000. Sanders Capital LLC bought a new position in Humana during the 4th quarter worth $489,300,000. Putnam Investments LLC increased its position in Humana by 550.3% during the 4th quarter. Putnam Investments LLC now owns 875,489 shares of the insurance provider’s stock worth $400,808,000 after buying an additional 740,858 shares during the period. Allspring Global Investments Holdings LLC increased its position in Humana by 255.4% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 620,793 shares of the insurance provider’s stock worth $215,241,000 after buying an additional 446,124 shares during the period. Finally, 1832 Asset Management L.P. increased its position in Humana by 154.3% during the 4th quarter. 1832 Asset Management L.P. now owns 270,900 shares of the insurance provider’s stock worth $124,021,000 after buying an additional 164,392 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

HUM has been the topic of several recent research reports. Bank of America increased their price objective on Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research report on Monday, May 20th. TD Cowen lowered their price objective on Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a research report on Tuesday, April 2nd. Barclays lowered their price objective on Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 2nd. Oppenheimer decreased their price target on Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Finally, The Goldman Sachs Group decreased their price target on Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Fourteen research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $409.55.

Humana Price Performance

Humana stock traded up $3.11 during midday trading on Wednesday, reaching $376.47. The company’s stock had a trading volume of 206,094 shares, compared to its average volume of 1,778,672. The business has a 50-day moving average price of $351.68 and a 200-day moving average price of $347.92. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $530.54. The stock has a market cap of $45.36 billion, a PE ratio of 23.37, a price-to-earnings-growth ratio of 2.14 and a beta of 0.51. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The firm had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same period last year, the firm posted $9.38 earnings per share. The business’s revenue for the quarter was up 10.7% on a year-over-year basis. On average, sell-side analysts predict that Humana Inc. will post 16.27 EPS for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date is Friday, June 28th. Humana’s payout ratio is 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.